Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07193875 · ClinicalTrials.gov registry record · Phase 4
Efavirenz (EFV) Intensification
A Phase 4 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 7
- Enrollment target
NCT07193875: Completed Phase 4 study, sponsored by Washington University School of Medicine.
NCT07193875 is a Phase 4 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 7 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07193875, a Phase 4 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 7 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to see if Efavirenz (EFV) intensification to a baseline combination antiretroviral regimen (cART) can help reduce the size of the latent reservoir in people living with HIV (PLWH). The main questions this study aims to address are: 1. is the addition of EFV to a cART regimen safe and well tolerated? 2. Is there a reduction in the blood and tissue HIV reservoir after intensification? Researchers will compare each participants reservoir size prior to and post EFV intensification.
Primary Outcome
Safety as measured by number of serious adverse events, adverse events leading to study discontinuation or adverse events considered clinically significant
Interventions
- DRUG Efavirenz 600mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2023-02-09 |
| Est. Completion | 2024-12-16 |
| Phase | Phase 4 |
What the finished NCT07193875 record still lists
NCT07193875 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Efavirenz 600mg is the first listed.
NCT07193875 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07193875 about?
NCT07193875 is a clinical study titled "Efavirenz (EFV) Intensification". The goal of this clinical trial is to see if Efavirenz (EFV) intensification to a baseline combination antiretroviral regimen (cART) can help reduce the size of the latent reservoir in people living with HIV (PLWH). The main questions this study aims to address are: 1. is the addition of EFV to a c...
What is the current status of trial NCT07193875?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 7 participants. The study started on 2023-02-09. Estimated completion is 2024-12-16.
What interventions are being tested in trial NCT07193875?
The interventions under investigation include: Efavirenz 600mg (DRUG).
Who is sponsoring clinical trial NCT07193875?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07193875's enrollment target sits among peer trials
7 1981st of 2000 higher than 18 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI